These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37721437)

  • 1. Correction to "Tumor Cell-Derived Extracellular Vesicle-Coated Nanocarriers: An Efficient Theranostic Platform for the Cancer-Specific Delivery of Anti-miR-21 and Imaging Agents".
    Bose RJ; Kumar SU; Zeng Y; Afjei R; Robinson E; Lau K; Bermudez A; Habte F; Pitteri SJ; Sinclair R; Willmann JK; Massoud TF; Gambhir SS; Paulmurugan R
    ACS Nano; 2023 Oct; 17(19):19470. PubMed ID: 37721437
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumor Cell-Derived Extracellular Vesicle-Coated Nanocarriers: An Efficient Theranostic Platform for the Cancer-Specific Delivery of Anti-miR-21 and Imaging Agents.
    Bose RJC; Uday Kumar S; Zeng Y; Afjei R; Robinson E; Lau K; Bermudez A; Habte F; Pitteri SJ; Sinclair R; Willmann JK; Massoud TF; Gambhir SS; Paulmurugan R
    ACS Nano; 2018 Nov; 12(11):10817-10832. PubMed ID: 30346694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving anti-cancer drug delivery performance of magnetic mesoporous silica nanocarriers for more efficient colorectal cancer therapy.
    Iranpour S; Bahrami AR; Nekooei S; Sh Saljooghi A; Matin MM
    J Nanobiotechnology; 2021 Oct; 19(1):314. PubMed ID: 34641857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Theranostic Aspects: Treatment of Cancer by Nanotechnology.
    Sarkar B; Paira P
    Mini Rev Med Chem; 2018; 18(11):969-975. PubMed ID: 29189149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal delivery of targeted polyfunctional gold-iron oxide nanoparticles loaded with therapeutic microRNAs for combined theranostic multimodality imaging and presensitization of glioblastoma to temozolomide.
    Sukumar UK; Bose RJC; Malhotra M; Babikir HA; Afjei R; Robinson E; Zeng Y; Chang E; Habte F; Sinclair R; Gambhir SS; Massoud TF; Paulmurugan R
    Biomaterials; 2019 Oct; 218():119342. PubMed ID: 31326657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombus-specific theranostic nanocomposite for codelivery of thrombolytic drug, algae-derived anticoagulant and NIR fluorescent contrast agent.
    Chang LH; Chuang EY; Cheng TM; Lin C; Shih CM; Wu AT; Jheng PR; Lu HY; Shih CC; Mi FL
    Acta Biomater; 2021 Oct; 134():686-701. PubMed ID: 34358695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multifunctional theranostic platform based on phthalocyanine-loaded dendrimer for image-guided drug delivery and photodynamic therapy.
    Taratula O; Schumann C; Naleway MA; Pang AJ; Chon KJ; Taratula O
    Mol Pharm; 2013 Oct; 10(10):3946-58. PubMed ID: 24020847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic nanoparticles coated with polyarabic acid demonstrate enhanced drug delivery and imaging properties for cancer theranostic applications.
    Patitsa M; Karathanou K; Kanaki Z; Tzioga L; Pippa N; Demetzos C; Verganelakis DA; Cournia Z; Klinakis A
    Sci Rep; 2017 Apr; 7(1):775. PubMed ID: 28396592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gadolinium labeled polyelectrolyte nanocarriers for theranostic application.
    Szczęch M; Karabasz A; Łopuszyńska N; Bzowska M; Węglarz WP; Warszyński P; Szczepanowicz K
    Colloids Surf B Biointerfaces; 2019 Nov; 183():110396. PubMed ID: 31394424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of tumor progression and M2 microglial polarization by extracellular vesicle-mediated microRNA-124 in a 3D microfluidic glioblastoma microenvironment.
    Hong S; You JY; Paek K; Park J; Kang SJ; Han EH; Choi N; Chung S; Rhee WJ; Kim JA
    Theranostics; 2021; 11(19):9687-9704. PubMed ID: 34646393
    [No Abstract]   [Full Text] [Related]  

  • 11. Reduction sensitive hyaluronan-SS-poly(ε-caprolactone) block copolymers as theranostic nanocarriers for tumor diagnosis and treatment.
    Yang H; Wang N; Mo L; Wu M; Yang R; Xu X; Huang Y; Lin J; Zhang LM; Jiang X
    Mater Sci Eng C Mater Biol Appl; 2019 May; 98():9-18. PubMed ID: 30813097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell membrane coated nanocarriers - an efficient biomimetic platform for targeted therapy.
    Dash P; Piras AM; Dash M
    J Control Release; 2020 Nov; 327():546-570. PubMed ID: 32911013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decellularized Extracellular Matrix Hydrogels as a Delivery Platform for MicroRNA and Extracellular Vesicle Therapeutics.
    Hernandez MJ; Gaetani R; Pieters VM; Ng NW; Chang AE; Martin TR; van Ingen E; Mol EA; Sluijter JPG; Christman KL
    Adv Ther (Weinh); 2018 Jul; 1(3):. PubMed ID: 31544132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet extracellular vesicles are efficient delivery vehicles of doxorubicin, an anti-cancer drug: preparation and in vitro characterization.
    Wu YW; Lee DY; Lu YL; Delila L; Nebie O; Barro L; Changou CA; Lu LS; Goubran H; Burnouf T
    Platelets; 2023 Dec; 34(1):2237134. PubMed ID: 37580876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Theranostic nanocarriers combining high drug loading and magnetic particle imaging.
    Fuller EG; Scheutz GM; Jimenez A; Lewis P; Savliwala S; Liu S; Sumerlin BS; Rinaldi C
    Int J Pharm; 2019 Dec; 572():118796. PubMed ID: 31678389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-Performance Worm-like Mn-Zn Ferrite Theranostic Nanoagents and the Application on Tumor Theranostics.
    Sun Y; Yan C; Xie J; Yan D; Hu K; Huang S; Liu J; Zhang Y; Gu N; Xiong F
    ACS Appl Mater Interfaces; 2019 Aug; 11(33):29536-29548. PubMed ID: 31333014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-encapsulation of superparamagnetic nanoparticles and doxorubicin in PLGA nanocarriers: Development, characterization and in vitro antitumor efficacy in glioma cells.
    Luque-Michel E; Sebastian V; Larrea A; Marquina C; Blanco-Prieto MJ
    Eur J Pharm Biopharm; 2019 Dec; 145():65-75. PubMed ID: 31628997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomimetic cell membrane-coated nanocarriers for targeted siRNA delivery in cancer therapy.
    Huang X; Guo H; Wang L; Zhang Z; Zhang W
    Drug Discov Today; 2023 Apr; 28(4):103514. PubMed ID: 36736580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using magnetic mesoporous silica nanoparticles armed with EpCAM aptamer as an efficient platform for specific delivery of 5-fluorouracil to colorectal cancer cells.
    Kamil Mohammad Al-Mosawi A; Bahrami AR; Nekooei S; Saljooghi AS; Matin MM
    Front Bioeng Biotechnol; 2022; 10():1095837. PubMed ID: 36686226
    [No Abstract]   [Full Text] [Related]  

  • 20. Co-delivery of 5-fluorouracil and miRNA-34a mimics by host-guest self-assembly nanocarriers for efficacious targeted therapy in colorectal cancer patient-derived tumor xenografts.
    Xu J; Zhang G; Luo X; Wang D; Zhou W; Zhang Y; Zhang W; Chen J; Meng Q; Chen E; Chen H; Song Z
    Theranostics; 2021; 11(5):2475-2489. PubMed ID: 33500737
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.